Article Versions Notes

Lambiase C, Cancelli L, Tedeschi R, Grosso A, Rettura F, Salemmo R, Bottari A, Filippini F, Salvadori S, Valdiserra G, et al. Effects of γ-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study. Nutrients. 2026; 18(10):1569. https://doi.org/10.3390/nu18101569

Lambiase, Christian, Lorenzo Cancelli, Riccardo Tedeschi, Antonio Grosso, Francesco Rettura, Rebecca Salemmo, Andrea Bottari, Fabio Filippini, Stefano Salvadori, Giulia Valdiserra, and et al. 2026. "Effects of γ-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study" Nutrients 18, no. 10: 1569. https://doi.org/10.3390/nu18101569

Lambiase, C., Cancelli, L., Tedeschi, R., Grosso, A., Rettura, F., Salemmo, R., Bottari, A., Filippini, F., Salvadori, S., Valdiserra, G., Campigli, L., Antonioli, L., Fornai, M., de Bortoli, N., & Bellini, M. (2026). Effects of γ-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study. Nutrients, 18(10), 1569. https://doi.org/10.3390/nu18101569